Phoenix Life Sciences International Announces John Taleo as
Company's Global Head of Security
DENVER, CO --
April 16, 2019 -- InvestorsHub NewsWire -- Phoenix
Life Sciences International Limited (OTC: PLSI) ("Phoenix Life" or
the "Company"), an adaptive healthcare solutions company, today
announced that John Taleo has been appointed as the Company's
Global Head of Security.
In advance of
his retirement in February 2018, Taleo served as Acting
Commissioner of the Vanuatu Police Service and dedicated 40 years
of his career to the force's service. Prior to that role, he held
several positions with the Maritime Security in the Pacific in New
Zealand with his most prominent position being Deputy Commissioner
of Police. Additionally, Taleo was the Director of Vanuatu Police
College, Chief of Staff to the Office of the Police Commissioner,
and Assistant Superintendent of Vanuatu Prison Services.
"Throughout his
extensive career in security, John has worked with international
leaders and government changes and has proven his dedication to
security," said Martin Tindall, Chief Executive Officer of Phoenix
Life. "As we plan to expand our international operations, John's
tailored skillset will help drive success and security compliance
as we transform global healthcare."
Taleo has
received several prestigious awards throughout his career
recognizing his commitment to global safety and security. In 2006,
the U.S. Coast Guard recognized him for his outstanding performance
and he was awarded the Commissioner's Commendation Award for
Excellent Police Work. Taleo was also awarded the Vanuatu Service
Medal, U.N. Marshall Recognition, 20th Anniversary Independence
Medal, National Medal of Merit, Long Service & Good Conduct
Medal, Overseas Service Medal, Vanuatu Silva Jubili Medal, and
Commissioner's Commendation Advance Stage Award. Phoenix Life
intends to apply Taleo's comprehensive security experience to
remaining fully compliant with national security regulations and
legislation, as well as path the way for global distribution in
full compliance with treaties and controls regarding cannabis for
medical and research purposes.
"When working
internationally and within the cannabis industry, security proves
to be an extremely important part of company success," said John
Taleo, Global Head of Security of Phoenix Life. "I look forward to
utilizing and strengthening my expertise as I work to keep Phoenix
Life a secure and stable operation."
To learn more
about Phoenix Life Sciences International, please
visit https://phoenixlife.co/.
To learn more about Phoenix Life in Vanuatu and how to register for
blood sugar screenings, please visit https://phoenixlife.vu.
###
About
Phoenix Life Sciences International Limited
Phoenix Life
Sciences International Limited is an adaptive healthcare solutions
company. Our business is to advance research and integrate programs
and manufacturing of products that target and treat diabetes, pain,
cancer, and address psychological, gastrointestinal, autoimmune,
neurological and sleep disorders. We strive to create partnerships
and integrate these programs for human health into communities
worldwide as part of our Global Health Initiative.
FORWARD-LOOKING
STATEMENTS
Information
contained in this press release regarding Phoenix Life Sciences
International, Limited and its subsidiaries, (the "Companies") may
constitute forward-looking statements or statements which may be
deemed or construed to be forward-looking statements. The words
"plan", "forecast", "anticipates", "estimate", "project", "intend",
"expect", "should", "believe," and similar expressions are intended
to identify forward-looking statements. These forward-looking
statements involve, and are subject to, known and unknown risks,
uncertainties and other factors which could cause the Company's
actual results, performance (financial or operating) or
achievements to differ from the future results, performance
(financial or operating) or achievements expressed or implied by
such forward-looking statements. The risks, uncertainties and other
factors are more fully discussed in the Company's filings with the
U.S. Securities and Exchange Commission. All forward-looking
statements attributable to the Companies herein are expressly
qualified in their entirety by the above-mentioned cautionary
statement. The Companies disclaim any obligation to update
forward-looking statements contained in this press release, except
as may be required by law.
FOOD AND
DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements
have not been evaluated by the FDA and therefore the products sold
by Phoenix Life Sciences International are not available in the
U.S.
LEGAL
DISCLOSURE
Phoenix Life
Sciences International does not sell or distribute any products in
the United States that are in violation of the United States
Controlled Substances Act (US.CSA). This company does not grow,
sell, and distribute cannabis-based products in the United States
and is solely involved with the legal distribution of medical
cannabis-based products within certain international markets
outside of the United States.
Investor
Contact:
Phone:
1.888.717.5655 or international +1.720.699.7222
E-mail: investor.relations@phoenixlife.co
Media
Contact:
Kathryn
Reinhardt
CMW
Media
Kathryn@cmwmedia.com
619-972-3089